HCV assays are described. The assays utilize a 24 kd protein capable of binding the E2 envelope protein of hepatitis C virus (HCV), or functionally equivalent variants or fragments of the 24 kd protein.

 
Web www.patentalert.com

< Hepatitis C virus inhibitors

> Thionucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase

~ 00407